In this latest edition of the Healthspan Expert Q & A, we speak with Dr. Gerard Karsenty, the Paul A. Marks M.D., professor and chair of the department of Genetics and Development at Columbia University Medical Center about his research into bone biology and its effect on aging.
For this edition of the Healthspan Expert Q & A, we talk with Todd T. Brown, M.D., Ph.D., associate professor of Medicine and Epidemiology, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, about HIV and how it affects the healthspan of older adults. We also discuss his research.
Q: Could you please tell us more about your background as a researcher?
TB: I’m an endocrinologist who has been working in the area of metabolic and endocrine abnormalities in HIV-infected persons for the past 15 years. My areas of interest are hypogonadism, osteoporosis, diabetes, and body composition changes in HIV infection, particularly as they relate to aging-related outcomes such as frailty and cardiovascular disease.
For this edition of the Healthspan Expert Q & A, we talk with Valter Longo, Ph.D., Edna Jones Professor in Gerontology and Professor in Biological Science at USC. He most recently gave a lecture on nutrition, fasting, longevity, and diseases for the Trans-NIH GeroScience Interest Group’s (GSIG) seminar series.
Q: What led you to pursue a career in longevity research?
VL: I have worked on longevity research since I was an undergraduate. I always thought it was a great way to combine science and medicine.
In this edition of the Healthspan Expert Q & A, we talk with a new researcher to the field of healthspan, Allyson Palmer, an M.D.-Ph.D. student at the Mayo Clinic College of Medicine. Allyson shares her interest in aging biology, her own research projects, and her future plans. She’s part of the next generation of experts whose research will help lead to more discoveries into why our bodies age.
Q: Can you give us some insights into your academic background?
AP: I received my B.A. in Biochemistry and Molecular Biology at The College of Wooster in Wooster, Ohio, in 2010. During my second semester at Wooster, I became involved in the research lab of my Continue reading
The April 2016 Healthspan Campaign newsletter is now available! Get the latest on news from the Disease Drivers in Aging: 2016 Advances in Geroscience Summit, a new healthspan infographic, and more! Get the April 2016 newsletter here.
The Disease Drivers in Aging: 2016 Advances in Geroscience Summit brought together the nation’s top science experts, as well as various associated stakeholders, to the New York Academy of Sciences in New York City on April 13 and 14 for presentations and discussions about advances in the field of geroscience.
In October 2013, the Advances in Geroscience: Impact on Healthspan and Chronic Disease summit provided an introduction to the field of geroscience, which explores the common connections between aging and disease. Discussions from the conference produced a consensus on the seven “pillars of aging:” adaption to stress, epigenetics, inflammation, macromolecular damage, metabolism, proteostasis, and stem cells and regeneration. Through study of these processes, experts hope to find ways to slow down aging and thus reduce the risk for all chronic diseases.
According to Felipe Sierra, Ph.D., director, Division of Aging Biology at the National Institute on Aging, “When we had the 2013 summit, it was a quite a success. People were energized.”
In our latest Healthspan Expert Q & A, we talk with Dana Goldman, Ph.D., professor and Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy & Economics, about aging demographics in the U.S. Please note Dr. Goldman’s opinions are his own.
Q: Please give us a background into your interest into the aging of the U.S. population?
DG: Ironically, I first became interested in aging when I was studying obesity in younger populations. We all know obesity is a public health problem, and we were studying the value of interventions to reduce weight at earlier ages. However, it soon became clear that such interventions are not well-targeted and hence can be very expensive. We started to look at prevention at older ages, and what we found was that interventions at older ages Continue reading
While there are 7,000 geriatricians practicing in the U.S. right now, there’s a larger issue. We will need many more in the coming years. According to the American Geriatrics Society, we’ll need approximately 30,000 by 2030.
Why? Older Americans over 65 will comprise 20 percent of the population by 2030, jumping from 35 million in 2000 to an estimated 70 million. This jump will be due in part to increased life expectancy.
The February Healthspan Campaign enewsletter is hot off the digital presses. Stories include: geriatricians, a longevity faceoff, upcoming conferences, and the latest in healthy aging research.
Get it here.